BioSpace News Archive

Biotech Beach

DERMALA, A Consumer Dermatology Company, Announces Issuance of the 4th U.S. Patent Covering Human Microbiome to Treat and Prevent Eczema

DERMALA Inc., a science-based consumer dermatology company developing novel, microbiome-based solutions for chronic skin conditions, announced today the issuance of the U.S. Patent No. 11,364,214 - COMPOSITIONS AND METHODS FOR TREATING ECZEMA.

June 21, 2022
·
2 min read
Business

Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors

Ms. Quigley’s Broad Biotechnology Industry Experience Encompasses Leadership Positions in Executive Management, Operations and Legal Affairs.

June 21, 2022
·
6 min read
Drug Development

Affinivax Presents Data for Enhanced Protection Against Serotype 3 in Next-Generation Pneumococcal Vaccine

Preclinical data show synergistic protective effect of anti-protein and anti-polysaccharide antibodies in a highly virulent model of serotype 3 invasive pneumococcal disease.

June 21, 2022
·
5 min read
Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics

Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics.

June 21, 2022
·
4 min read
Genetown

PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform

GC 2400 solution streamlines performance and delivers superior precision for high throughput environments.

June 21, 2022
·
3 min read
Genetown

BeiGene Announces Acceptance of Supplemental Biologics License Application in China for Anti-PD-1 Inhibitor Tislelizumab

Submission seeks marketing authorization for use with chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma whose tumor expresses PD-L1.

June 21, 2022
·
8 min read
Business

Opus Genetics Appoints Ben Yerxa, Ph.D., as Permanent Chief Executive Officer

Industry veteran and experienced CEO will continue to lead the company as its AAV-based gene therapies for inherited retinal diseases approach the clinic.

June 21, 2022
·
3 min read
Pharm Country

Intercept Announces PBC Data Presentations at The International Liver Congress™ 2022

Intercept Pharmaceuticals, Inc. today announced that multiple abstracts highlighting the benefits of obeticholic acid (OCA) in individuals with primary biliary cholangitis (PBC) will be presented at the International Liver Congress™ 2022, the 57th Annual Meeting of the European Association.

June 21, 2022
·
17 min read
Genetown

Appalachian Regional Healthcare Selects Biofourmis Tech for Home Hospital Programs, Including Rural Healthcare Study

Biofourmis announced that Appalachian Regional Healthcare, based in Lexington, Ky., will be using Biofourmis’ technology to support a new program delivering acute hospital-level care inside patients’ homes, including a clinical trial studying this care model in rural areas.

June 21, 2022
·
5 min read
Health Kiosk Market to Witness Comprehensive Growth by 2027, Latest TMR Study

Wilmington, Delaware, United States: According to a new market report pertaining to the global health kiosk market, published by Transparency Market Research, the global health kiosk market is projected to reach a value of ~US$ 2 Bn by 2027, expanding at a CAGR of ~18% from 2019 to 2027.

June 21, 2022
·
5 min read